MedPath
TGA Approval

Doxorubicin hydrochloride injection 50 mg in 25 mL (18) (332664)

332664

Doxorubicin hydrochloride injection 50 mg in 25 mL (18)

Pfizer (Perth) Pty Ltd

March 27, 2020

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

doxorubicin hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Doxorubicin hydrochloride injection 50 mg in 25 mL (18) (332664) - TGA 批准文号 | MedPath